Medical Marijuana for Crohn's Disease and IBD in Florida

Crohn's disease is one of the specifically named qualifying conditions for medical marijuana under Florida Statute 381.986 — not lumped into a general category, but listed individually. That distinction matters because it reflects the growing recognition that medical cannabis can play a meaningful role in managing inflammatory bowel disease (IBD).

If you've been living with Crohn's disease or ulcerative colitis, you already know that conventional treatments don't work perfectly for everyone. Biologics, immunomodulators, and steroids are important tools, but they come with significant side effects and don't always provide complete symptom relief. For many IBD patients, medical cannabis fills the gaps that conventional therapy leaves behind.

How Medical Cannabis Interacts with IBD

Your gastrointestinal tract is loaded with cannabinoid receptors. The endocannabinoid system (ECS) is heavily involved in regulating gut motility (how fast food moves through your intestines), intestinal inflammation, pain signaling from the gut, and the gut-brain connection that drives so many IBD symptoms.

This isn't coincidental — the ECS plays a fundamental role in gut homeostasis, and disruptions in endocannabinoid signaling have been identified in IBD patients.

Medical cannabis works through several mechanisms relevant to Crohn's and ulcerative colitis:

Anti-inflammatory effects. Both THC and CBD reduce inflammation through different pathways. CBD inhibits pro-inflammatory cytokines and modulates immune cell activity in the gut lining. THC acts on CB1 and CB2 receptors to reduce inflammatory signaling. This is particularly relevant in IBD, where chronic inflammation damages the intestinal wall.

Pain modulation. Abdominal pain is one of the most common and debilitating IBD symptoms. THC provides direct analgesic effects by modulating pain signals in the central nervous system, while CBD addresses inflammatory pain at the gut level.

Motility regulation. THC slows gut motility — which is why some recreational users experience constipation. For Crohn's patients who suffer from chronic diarrhea and urgency, this effect can be genuinely therapeutic. It reduces the frequency and urgency of bowel movements, which for many patients is the symptom that most disrupts daily life.

Appetite stimulation. Many IBD patients struggle with appetite loss, either from the disease itself or from medication side effects. THC's ability to stimulate appetite and reduce nausea helps patients maintain nutrition — which is critical for healing.

Nausea reduction. IBD-related nausea is common and often undertreated. THC is one of the most effective anti-nausea compounds available.

What the Research Shows

The evidence for medical cannabis in IBD is encouraging, though it's important to be honest about its limitations.

Symptom improvement: Several clinical studies have shown that medical cannabis significantly improves quality of life, reduces pain, improves sleep, and decreases the number of daily bowel movements in Crohn's patients. A landmark Israeli study found that 65% of Crohn's patients using medical cannabis achieved clinical remission.

Inflammation: Here's where it gets more nuanced. While patients consistently report feeling better — less pain, fewer symptoms, better quality of life — most studies have NOT shown significant reductions in objective inflammatory markers (like CRP or fecal calprotectin) or endoscopic evidence of mucosal healing.

What does this mean practically? It means medical cannabis is currently best understood as a symptom management tool rather than a disease-modifying therapy. It makes you feel better and function better, but it may not be changing the underlying disease activity the way biologics or immunomodulators can.

This is why I never recommend medical cannabis as a replacement for conventional IBD therapy. It works best as an adjunct — used alongside your prescribed medications to address symptoms that those medications don't fully control.

Products and Approaches for IBD

Oral products are usually preferred. Since IBD is a gastrointestinal condition, oral administration — tinctures, capsules, or edibles — delivers cannabinoids directly to the GI tract. Sublingual tinctures are particularly useful because they allow precise dosing and relatively quick onset (15-30 minutes).

THC:CBD ratios. A balanced 1:1 ratio is often a good starting point for IBD patients. The CBD contributes anti-inflammatory effects while moderating the psychoactivity of THC. Some patients find they need higher THC ratios for adequate pain and diarrhea control, especially during flares.

Inhaled products for acute symptoms. During a flare — when abdominal pain is severe, nausea is intense, or diarrhea is uncontrollable — inhaled medical cannabis provides the fastest relief. Many IBD patients keep a vaporizer or flower available for these situations while using oral products for daily management.

Topical products generally aren't useful for IBD since the inflammation is internal, not at the skin surface.

Start low, go slow. This is especially important for IBD patients because THC can cause abdominal discomfort at high doses in some individuals. Begin with a low dose (2.5-5mg THC) and increase gradually over days to weeks.

Important Considerations for IBD Patients

Don't stop your prescribed medications. If you're on a biologic (Humira, Remicade, Stelara, etc.), an immunomodulator (azathioprine, 6-MP), or any other IBD medication, do not stop or reduce it without discussing with your gastroenterologist. Medical cannabis supplements your treatment — it doesn't replace it.

Tell your GI doctor. Most gastroenterologists are aware that their IBD patients use medical cannabis, and many are supportive. Open communication ensures you receive coordinated care and that your GI doctor can monitor your disease activity appropriately.

Monitor your symptoms. Keep a simple log of bowel frequency, pain levels, and any changes after starting medical cannabis. This helps your physician adjust your regimen and helps your GI doctor assess whether your disease is truly improving or just symptomatically masked.

Be cautious with edibles during flares. During active flares, absorption from the GI tract can be unpredictable. Sublingual tinctures or inhaled products may be more reliable during these periods.

Getting Certified in Florida

Crohn's disease is explicitly listed as a qualifying condition — certification is straightforward:

1. Schedule a telehealth or in-person evaluation with a qualified physician
2. Discuss your Crohn's disease or IBD diagnosis, current treatment, and symptoms
3. Receive your certification (entered into the registry same day)
4. Complete your state application ($75 fee)
5. Receive your temporary card and begin visiting dispensaries

You do not need to bring endoscopy reports, lab results, or a letter from your gastroenterologist. Your certifying physician will evaluate your condition based on your medical history and presentation.

Having said that, if you do have medical records available, they can help your physician provide more targeted product and dosing recommendations.

FAQ

Does medical marijuana help with ulcerative colitis too, or just Crohn's?

While only Crohn's disease is specifically named in Florida statute, ulcerative colitis can be certified under the "conditions of the same kind or class" provision. The mechanisms and evidence are similar for both conditions. Many UC patients are successfully certified in Florida.

Can medical marijuana cause flares?

There's no evidence that medical cannabis causes IBD flares. Some patients experience mild GI discomfort when starting, particularly at higher doses, but this typically resolves with dose adjustment. Edibles with added sugars, artificial ingredients, or high fat content could theoretically irritate the gut in sensitive patients — simpler formulations are preferable.

Will medical marijuana show up in my GI doctor's drug tests?

Most gastroenterologists don't routinely drug test patients. If your GI practice does test, your medical marijuana card should protect you from negative consequences. Regardless, the best approach is to tell your GI doctor directly.

What if I'm on immunosuppressants — is medical marijuana safe?

Medical cannabis does not significantly impair immune function and is generally safe to use alongside immunosuppressants. However, if you're on immunosuppressant therapy, avoid smoking flower (which can introduce pathogens) and opt for vaporizers, edibles, or tinctures instead.

How long before I notice improvement in my IBD symptoms?

Many patients notice reduced pain, nausea, and urgency within the first few doses. Optimal symptom management usually takes 2-4 weeks of gradual dose adjustment. If you're not seeing meaningful improvement after 6-8 weeks with proper dosing guidance, medical cannabis may not be the right tool for your specific situation.

Take the Next Step

Living with Crohn's disease or ulcerative colitis is hard enough without leaving effective treatment options on the table. If you're interested in adding medical cannabis to your IBD management plan, [start your evaluation here](/start). Dr. Tae Y. Kim, DO, offers same-day telehealth evaluations for patients throughout Florida.